Literature DB >> 34094726

Atypical Presentation of Idiopathic Retroperitoneal Fibrosis Effectively Treated With Colchicine After Lymphoma Misdiagnosis.

Ellery Altshuler1.   

Abstract

Idiopathic retroperitoneal fibrosis (RPF) is a rare disease characterized by a fibro-inflammatory mass encasing the abdominal aorta. We report a case of a 43-year-old man with an unusual presentation of RPF who was initially misdiagnosed with lymphoma. Our patient presented with constipation and did not have common findings such as ureteral displacement or renal impairment. Our patient had a complicated disease course complicated by multiple treatment failures and pulmonary embolism. We discuss the patient's first 100 months of treatment, which included the use of prednisone, mycophenolate, tamoxifen, methotrexate, azathioprine, and, now, colchicine. Our case demonstrates that physicians should maintain an index of suspicion for RPF in patients with a homogenously attenuated mass encasing the anterior aorta. It also serves as one example in which RPF appeared to be responsive to colchicine.
Copyright © 2021, Altshuler et al.

Entities:  

Keywords:  abdominal aorta; acute pulmonary embolism; autoimmune; colchicine; idiopathic retroperitoneal fibrosis; igg4; lymphoma

Year:  2021        PMID: 34094726      PMCID: PMC8169009          DOI: 10.7759/cureus.14756

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

1.  Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation.

Authors:  Paul J Scheel; Nancy Feeley
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

2.  Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes.

Authors:  Tanaz A Kermani; Cynthia S Crowson; Sara J Achenbach; Harvinder S Luthra
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

Review 3.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

4.  Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

Authors:  E F H van Bommel; I Jansen; T R Hendriksz; A L H J Aarnoudse
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

5.  Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study.

Authors:  Matteo Goldoni; Silvia Bonini; Maria L Urban; Alessandra Palmisano; Giuseppe De Palma; Elisa Galletti; Marco Coggiola; Carlo Buzio; Antonio Mutti; Augusto Vaglio
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

6.  Asbestos exposure as a risk factor for retroperitoneal fibrosis.

Authors:  Toomas Uibu; Panu Oksa; Anssi Auvinen; Eero Honkanen; Kaj Metsärinne; Heikki Saha; Jukka Uitti; Pekka Roto
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

7.  Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series.

Authors:  Jorge Vega; Helmuth Goecke; Héctor Tapia; Eduardo Labarca; Mario Santamarina; Gonzalo Martínez
Journal:  Am J Kidney Dis       Date:  2008-12-31       Impact factor: 8.860

Review 8.  Retroperitoneal fibrosis: a review of clinical features and imaging findings.

Authors:  Carmel G Cronin; Derek G Lohan; Michael A Blake; Clare Roche; Peter McCarthy; Joseph M Murphy
Journal:  AJR Am J Roentgenol       Date:  2008-08       Impact factor: 3.959

9.  Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study.

Authors:  Baris Bakir; Fatma Yilmaz; Rustu Turkay; Sevda Ozel; Bilge Bilgiç; Arzu Velioglu; Bulent Saka; Artur Salmaslioglu
Journal:  Radiology       Date:  2014-04-01       Impact factor: 11.105

10.  Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.

Authors:  Arezou Khosroshahi; Mollie N Carruthers; John H Stone; Shweta Shinagare; Nisha Sainani; Robert P Hasserjian; Vikram Deshpande
Journal:  Medicine (Baltimore)       Date:  2013-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.